Found: 1
Select item for more details and to access through your institution.
Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 6, p. 555, doi. 10.1007/s40261-020-00909-3
- By:
- Publication type:
- Article